SCHEMBL306418

SCHEMBL306418

O=S(=O)(O)c1ccc(O)c(Cl)c1.[Na]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
HSD17B10 Q99714 4/20 0.59
KDM4E B2RXH2 1/20 0.53
HPGD P15428 1/20 0.53
PTGS1 P23219 1/20 0.51
PTGS2 P35354 1/20 0.51
TSHR P16473 3/20 0.48
LMNA P02545 1/20 0.48
HSD17B3 P37058 1/20 0.47
HSD17B2 P37059 1/20 0.47
SERPINE1 P05121 3/20 0.45
CA2 P00918 3/20 0.45
CA1 P00915 2/20 0.45
CA12 O43570 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA5A P35218 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1807429 1.00 ALDH1A1 (0.59) ALDH1A1HSD17B10KDM4EHPGDPTGS1
SCHEMBL306416 0.98 ALDH1A1 (0.57) ALDH1A1HSD17B10KDM4EHPGDPTGS1
SCHEMBL10422850 0.84 ALDH1A1 (0.55) ALDH1A1HSD17B10KDM4EHPGDPTGS1
SCHEMBL9341624 0.84 GAA (0.57) ALDH1A1HSD17B10PTGS1PTGS2TSHR
SCHEMBL29598983 0.84 GAA (0.57) ALDH1A1HSD17B10PTGS1PTGS2TSHR
SCHEMBL68932 0.84 GAA (0.57) ALDH1A1HSD17B10PTGS1PTGS2TSHR
SCHEMBL1803937 0.83 PTGS1 (0.66) KDM4EPTGS1PTGS2CA2CA1
SCHEMBL2649250 0.83 PTGS1 (0.51) ALDH1A1HSD17B10PTGS1PTGS2TSHR
SCHEMBL29389290 0.82 APEX1 (0.48) ALDH1A1HSD17B10KDM4EHPGDTSHR
SCHEMBL474108 0.82 APEX1 (0.48) ALDH1A1HSD17B10KDM4EHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470860-B2 Phenyl-sulfamates as aromatase inhibitors STERIX LIMITED (GB) 2013-06-25 US disclosed
EP-1966166-B1 1,2,4-TRIAZOL-l-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMOURS STERIX LTD (GB) 2013-01-23 EP disclosed
US-8093279-B2 Compound STERIX LIMITED (GB) 2012-01-10 US disclosed
US-8022224-B2 1,2,4-triazol-1-yl bisphenyl derivatives for use in the treatment of endocrine-dependent tumors STERIX LIMITED (GB) 2011-09-20 US disclosed
US-20110021586-A1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS STERIX, LIMITED (GB) 2011-01-27 US disclosed
US-7763642-B2 Phenyl-sulfamates as aromatase inhibitors STERIX LTD. (GB) 2010-07-27 US disclosed
US-20100173963-A1 COMPOUND STERIX LIMITED (GB) 2010-07-08 US disclosed
EP-1753732-B1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS STERIX LTD (GB) 2009-12-02 EP disclosed
US-20080319037-A1 1,2,4-TRIAZOL-1-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMORS STERIX LIMITED (GB) 2008-12-25 US disclosed
EP-1966166-A1 1,2,4-TRIAZOL-l-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMOURS Sterix Limited (GB) 2008-09-10 EP disclosed
WO-2007068905-A1 1,2,4-TRIAZOL-l-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMOURS STERIX LIMITED (GB) 2007-06-21 WO disclosed
US-20070117855-A1 Phenyl-sulfamates as aromatase inhibitors STERIX LIMITED (GB) 2007-05-24 US disclosed
EP-1753732-A1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS Sterix Limited (GB) 2007-02-21 EP disclosed
WO-2005118560-A1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS STERIX LIMITED (GB) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117855-A1 Phenyl-sulfamates as aromatase inhibitors CYP19A1, CYP17A1, CYP21A2 ALDH1A1 1209/4885HSD17B10 111/4885KDM4E 378/4885
US-20080319037-A1 1,2,4-TRIAZOL-1-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMORS CYP19A1, CYP21A2, CBR1 ALDH1A1 625/4885HSD17B10 216/4885KDM4E 930/4885
US-20100173963-A1 COMPOUND CBR3, CBR1, OXSR1 ALDH1A1 1841/4885HSD17B10 1729/4885KDM4E 990/4885
US-20110021586-A1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS CYP19A1, CYP17A1, CYP21A2 ALDH1A1 1209/4885HSD17B10 111/4885KDM4E 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.